July 16, 2006 |
Dr. Thomas J. Walsh, a physician-researcher for the National Institutes of Health, has added to his income and bolstered his lab with checks from drug companies, according to interviews and government records. The NIH would not comment on Walsh's relationship with industry, including whether he had obtained permission for outside work or had reported the income.
October 18, 2001 |
To stave off panic and hoarding of the name-brand antibiotic Cipro, the U.S. Food and Drug Administration this week is expected to approve two common antibiotics for treatment of the virulent inhaled form of anthrax. The move comes as supplies of Cipro are dwindling so quickly that pharmacies and wholesalers have begun to ration it. "We hope that this will make the lay public understand that there are alternative antibiotics available," said Dr.